Executive Summary
Clinical studies show that up to 29% of lipoaspirate samples arrive at the laboratory with detectable microbial contamination — and this figure rises to 38% after thawing.
The implication is straightforward: inadequate asepsis in the surgical field is not only a risk to the patient during surgery — it also puts at risk the quality of the biological material that will be cryopreserved and used in a future procedure. Confirmed contamination is an absolute rejection criterion in the LipAge Score.
29%
contamination upon arrival at the laboratory
23%
contamination in other autologous tissues
12.6%
bacterial contamination in bone allografts
01
Primary Contamination Vectors
- Endogenous skin flora: the primary vector — Staphylococcus epidermidis, S. aureus and Corynebacterium spp. mechanically carried by the cannula
- Contact contamination: the surgeon's gloves in contact with the cannula handle transfer microorganisms after just a few minutes of skin contact
- Environmental contamination: in rooms without laminar airflow or adequate pressure, microbial particles settle on the field and containers
- Inadequate instruments: cold sterilization (glutaraldehyde) does not eliminate rapidly growing atypical mycobacteria (RGM)
- Delayed glove changes: the most frequently neglected measure — contaminated gloves that touch the cannula shaft transfer flora directly
02
Why Cryopreservation Does Not Solve the Problem
✅ DOES: Suspend all metabolic activity — bacteria remain inactive during storage in liquid N₂ (-196°C).
✅ DOES: Preserve adipose tissue cell viability for years when processing is adequate.
❌ DOES NOT: Sterilize. Cryopreserved bacteria survive thawing and resume metabolic activity.
❌ DOES NOT: Compensate for lapses in asepsis in the surgical field. The Cryopraxis laboratory receives what the surgeon sends.
Bucky & May (2017) documented an increase in the contamination rate from 29% (upon arrival) to 38% after thawing — suggesting that the thawing process may create favorable conditions for the multiplication of microorganisms already present.
03
Asepsis Protocol for LipAge Collection
Field Preparation — Before Incision
- Cleanse with povidone-iodine surgical scrub or 4% chlorhexidine, followed by an alcohol-based antiseptic. Minimum contact time: 3 minutes. Allow to dry completely.
- Cover the entire operative area with sterile surgical drapes. No nonsterile surface should be accessible within the field.
Equipment and Instruments
- Sterilize exclusively in a steam autoclave — cold sterilization is NOT accepted for cannulas and suction tubing.
- Use only the proprietary LipAge kit designed for direct collection into a closed sterile container.
Intraoperative Practice — Critical Point
- Change gloves when switching donor sites or after any suspected contamination.
- Never touch the cannula shaft with a glove that has been in contact with unprepared skin.
- Keep the collection container in a closed system throughout collection.
04
LipAge Certified Checklist — Lipoaspirate Collection
Preoperative
- LipAge kit available and intact (check seal and expiration date)
- Instruments sterilized in a steam autoclave (do not accept cold sterilization)
- Room with airflow control and cleaning in accordance with facility protocols
Field Preparation
- Cleanse with chlorhexidine or povidone-iodine + alcohol-based antiseptic — allow to dry
- Sterile drapes positioned before contact with any instrument
- Sterile gloves checked before starting
Intraoperative
- Do not touch the cannula shaft with a glove that has been in contact with unprepared skin
- Change gloves when switching donor sites or after any suspected contamination
- Keep the collection vessel in a closed system throughout collection
- Surgical mask properly fitted; avoid talking over the open field
After Collection
- Close and label the vessel immediately (name, date, time, site)
- Place in a refrigerated transport container (2–8°C)
- Contact the LipAge team for pickup — do not leave at room temperature for more than 4 hours
- Do NOT freeze the material before shipping it to the Cryopraxis laboratory
References
- Bucky LP, May R Jr. Patient use of autologous cryopreserved intact adipose tissue. Cell and Tissue Engineering. 2017;1(3):224–235.
- Domenis R et al. Long-Term Biobanking of Intact Tissue from Lipoaspirate. Aesthet Surg J. 2019;39(Suppl_3):S44–S55. PMC6463172.
- Martínez-Rincón RO et al. Necrotizing soft tissue infection after liposculpture. Int J Surg Case Rep. 2020;77:536–540. PMC7710500.
- Cohen MS et al. Quality monitoring of microbial contamination of cryopreserved parathyroid tissue. Cell Tissue Bank. 2010;11(1):29–36.
- Eastlund T. Bacterial infection transmitted by human tissue allograft transplantation. Cell Tissue Bank. 2006;7(3):147–166.